We can readily understand why investors are attracted to unprofitable companies. For example, althou...
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is making waves in the biotechnology sector, capturing the...
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Get Free Report) has been assigned a consensus recommendat...
Celldex Therapeutics (NASDAQ:CLDX) Trading Down 5.5% - Time to Sell?...
Celldex Therapeutics, Inc. (NASDAQ:CLDX - Free Report) - Research analysts at Lifesci Capital issued...